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ABSTRACT
Introduction Disease- specific ‘vertical’ programmes 
and health system strengthening (HSS) ‘horizontal’ 
programmes are not mutually exclusive; programmes may 
be implemented with the dual objectives of achieving both 
disease- specific and broader HSS outcomes. However, there 
remains an ongoing need for research into how dual objective 
programmes are operationalised for optimum results.
Methods A qualitative study encompassing four grantee 
programmes from two partner countries, Tanzania and Sierra 
Leone, in the Comic Relief and GlaxoSmithKline ‘Fighting 
Malaria, Improving Health’ partnership. Purposive sampling 
maximised variation in terms of geographical location, 
programme aims and activities, grantee type and operational 
sector. Data were collected via semi- structured interviews. 
Data analysis was informed by a general inductive approach.
Results 51 interviews were conducted across the four 
grantees. Grantee organisations structured and operated 
their respective projects in a manner generally supportive of 
HSS objectives. This was revealed through commonalities 
identified across the four grantee organisations in terms of 
their respective approach to achieving their HSS objectives, 
and experienced tensions in pursuit of these objectives. 
Commonalities included: (1) using short- term funding for 
long- term initiatives; (2) benefits of being embedded in the 
local health system; (3) donor flexibility to enable grantee 
responsiveness; (4) the need for modest expectations; and (5) 
the importance of micro- innovation.
Conclusion Health systems strengthening may be pursued 
through disease- specific programme grants; however, 
the respective practice of both the funder and grantee 
organisation appears to be a key influence on whether HSS 
will be realised as well as the overall extent of HSS possible.
INTRODUCTION
External investment through both govern-
ment and non- government funding bodies 
in national disease- specific programmes 
has been widely practiced within the global 
health sector, often with substantial popu-
lation health impact.1–4 However, so called 
‘vertical’ programme investment has been 
critiqued on the basis that gains achieved may 
be unsustainable in the absence of broader 
health systems strengthening (HSS) or, in 
some cases, may have been achieved at the 
expense of the broader health system.5 This 
critique of vertical programme investment 
has contributed to a growth in ‘horizontal’ 
Key questions
What is already known?
 ► External investment in disease- specific programmes 
has been widely practiced within the global health 
sector, often with substantial population health 
impact.
 ► So called ‘vertical’ programme investment has been 
critiqued on the basis that gains achieved may be 
unsustainable in the absence of broader health sys-
tems strengthening (HSS) or, in some cases, may 
have been achieved at the expense of the broader 
health system.
 ► Dual objective programmes that aim to address both 
a specific disease and strengthen the broader health 
system are increasingly favoured because of this 
criticism.
What are the new findings?
 ► This qualitative study highlights five common ap-
proaches and experiences that may support the 
pursuit of HSS objectives within the scope of a 
disease- specific programme grant.
 ► Using short- term grants (2–3 years) to support long- 
term initiatives (10+ years).
 ► Delivery of project activities by partners embedded 
(or committed to embedding) within the local health 
system, that are responsive to local needs and HSS 
opportunities.
 ► Donor flexibility enabling grantee responsiveness.
 ► Using micro- innovation.
 ► Holding modest expectations of what level of HSS is 
achievable within often short- term programme time 
frames.
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programmes that aim to strengthen national health 
systems, providing the conditions necessary for effective 
and sustainable population health impact to be realised.6 7 
Disease- specific vertical programmes and HSS horizontal 
programmes are not mutually exclusive; both continue to 
be supported in the global health sector and programmes 
may be implemented with the dual objectives of achieving 
disease- specific and broader HSS outcomes. Indeed, HSS 
interventions have been defined as system- level interven-
tions that directly target one or more of the WHO’s six 
health system building blocks ((1) service delivery, (2) 
health workforce, (3) health information systems, (4) 
access to essential medicines, (5) financing and (6) lead-
ership/governance)) or disease- specific interventions or 
programmes that have important system- wide effects.8
How effective dual objective programmes have been, in 
terms of strengthening both the underlying health system 
and disease- specific programmes, remains somewhat 
uncertain. The purported HSS activities of many global 
health partners have been challenged on the grounds 
that they are not ‘systems strengthening’ as commonly 
defined, but rather unsustainable interventions 
primarily designed to ensure delivery of priority vertical 
programmes.9 10 An early review exploring the interac-
tions between global health partners, the disease- specific 
programmes they support, and broader HSS highlighted 
the need for robust and standardised outcome and 
impact assessment.4 However, few examples of HSS evalu-
ation that allow a wide and robust assessment of an inter-
vention’s impact on a health system have subsequently 
emerged.8 11 12 Those studies that have examined the 
interaction between disease- specific programmes and the 
broader health system continue to report mixed results, 
with evidence of both positive and negative impact.13–16 
Thus, there remains an ongoing need for research into 
how dual objective programmes may best be operation-
alised to support both disease- specific and broader HSS 
objectives.
This qualitative case study explores the experience of 
four organisations tasked with supporting HSS within 
the frame of a disease- specific programme grant; namely, 
the Comic Relief/GlaxoSmithKline ‘Fighting Malaria, 
Improving Health’ (FMIH) initiative.17 The primary study 
objective was to identify approaches to, and inherent 
tensions in, pursuing dual disease- specific and HSS 
objectives within the context of a relatively short- term 
(2–3 years) project grant. The secondary study objective 
was to explore perceived HSS contributions, as reported 
by the four FMIH grantee organisations and their respec-
tive stakeholders, and their apparent fit across the six 
health system building blocks defined by the WHO.18 In 
the absence of an objective outcome assessment (which 
was beyond the scope of this study), this component of 
our study affords a clearer picture as to the activities 
grantee organisations were working towards in pursuit of 
their HSS objectives and to what extent these activities 
align with a recognised HSS framework. Drawing on the 
study findings, which reveal commonalities in approach 
and experienced tensions in pursuit of recognisable 
(although unsubstantiated) HSS outcomes, we then 
propose an implementation model that may enhance 
the potential of disease- specific programme grants to 
facilitate HSS in low- income and middle- income country 
contexts. This model should remain hypothetical until 
such time as it can be tested within the context of a dual- 
objective programme with proven HSS outcomes.
METHODOLOGY
A qualitative study encompassing four grantee 
programmes from across two partner countries. Data 
were collected via semi- structured interviews (SSIs).
Study setting
Comic Relief (CR) and GlaxoSmithKline (GSK) formed 
a 5- year (2016–2021) strategic partnership to combat 
malaria and strengthen healthcare systems in Ghana, 
Mozambique, Sierra Leone, Tanzania and the Mekong 
subregion. Known as the ‘Fighting Malaria, Improving 
Health’ (FMIH) partnership, the programme awarded 
23 grants worth a total of £16.7 million to local non- 
government organisations (NGOs), and international 
development partners working within the partnership 
countries. Specifically, the partnership aimed to: improve 
health outcomes for people living in the partnership’s 
focus countries; strengthen health systems for tackling 
malaria in the partnership’s focus countries; and inspire 
global action against malaria by telling compelling stories 
that demonstrate need and impact. The 23 grants, made 
and managed by CR, all variously supported one or more 
of three intervention ‘pillars’: (1) improving the quality 
of health services for communities affected by malaria; 
(2) increasing demand for health services by commu-
nities affected by malaria; and (3) improving malaria 
surveillance and information systems at local and national 
levels (a fourth pillar ‘improving awareness of malaria’ 
was also included, although this was not HSS- focused). 
These three intervention pillars were informed by a 
consultative prioritisation exercise undertaken in each 
partner country prior to the formulation of the grant 
call. The FMIH partnership’s explicit focus on ‘strength-
ening health systems for tackling malaria’ positioned this 
funding scheme as an ideal candidate to explore grantee 
Key questions
What do the new findings imply?
 ► Both external funders and grantee organisations play a key role in 
supporting HSS gain through disease- specific grants;
 ► through empowering trusted, embedded implementing partners to 
seek out and exploit HSS opportunities that present within the con-
text of project delivery;
 ► and though fostering and resourcing an environment which enables 
partners to proactively and positively respond to HSS opportunities 
that can be reasonably accommodated.
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experiences of attempting to facilitate HSS within a 
disease- specific grant as did the partnerships commit-
ment to research- based learning. Tetra Tech (formerly 
Coffey International) was contracted by CR to support 
the monitoring, evaluation and learning dimension of 
the partnership across all focus countries. The study 
described in this paper, subcontracted to the Liverpool 
School of Tropical Medicine, was one component of the 
partnerships wider learning programme. Further infor-
mation about the FMIH programme, including the HSS 
objectives, intervention pillars and grantee programmes 
(including the four described below) can be found at: 
https://fightingmalariacouk/.
Defining health system strengthening
Grantees were not required by the programme funder 
to report against a defined set of HSS interventions 
and objectives. Similarly, the study team did not require 
participants to report against a specific definition of what 
constitutes a HSS outcome as opposed to what consti-
tutes a disease- specific programme outcome. Rather, 
study participants were free to self- report what they 
considered to be the HSS interventions and outcomes of 
their respective projects as well as the factors they consid-
ered important to achieving these contributions. This 
decision, in part, reflects the ongoing debate about what 
may or may not represent a HSS versus disease- specific 
programme intervention19 but, more importantly, 
allowed us to explore participant interpretations of the 
HSS concept. Given the absence of a defined assess-
ment of HSS outcome, the study findings should not be 
considered an objective account of the HSS contribution 
of grantee projects, nor should the study be considered 
a programme evaluation. Rather, the study findings are 
more appropriately considered a qualitative account of 
the perceptions and common experiences of a disparate 
group of grantees working towards a common, yet largely 
undefined, goal of supporting HSS within a disease- 
specific programme context.
Sample selection
Given operational considerations, a decision was made at 
the outset to limit data collection to 4 out of 23 grantees 
from two out of the five partner countries/regions. 
A purposive sampling strategy was employed at both 
country and grantee level, with the aim of maximising 
variation in terms of geographical location, intervention 
pillar (across the three as described above), programme 
activities (nil/minimal overlap between grantees), 
grantee type (local or international NGO) and opera-
tional sector (public, private). Sierra Leone and Tanzania 
were subsequently selected as the two ‘focal’ countries as 
their respective grantee programmes have been running 
the longest (ie, there has been greater opportunity for 
health systems impact in these two countries as compared 
with other partner countries). From a total of 11 grantee 
programmes in Sierra Leone (7) and Tanzania (4), 
two grantees were selected from each country. These 
included the: Kings College Global Health Partnership 
(KGHP); Health Poverty Action (HPA), Sierra Leone; 
the Tanzania Communication and Development Centre 
(TCDC); and Clinton Health Access Initiative (CHAI), 
Tanzania. HPA and CHAI are international NGOs with 
established national offices, TCDC is a national NGO and 
KGHP is a partnership established in 2013 between Kings 
College London (UK) and Connaught Hospital (Sierra 
Leone), College of Medicine and Allied Health Sciences, 
University of Sierra Leone and the Ministry of Health 
and Sanitation (Sierra Leone).
KGHP focused on strengthening management path-
ways for patients with fever within Sierra Leone’s 
largest referral hospital. HPA sought to improve access 
to malaria care for people who do not use services by 
(among other things) increasing awareness of the impor-
tance of seeking care and by training community- based 
health workers to treat malaria in the community. TCDC 
employed behaviour change communication approaches 
within target communities to promote prompt health 
seeking for febrile illness, adherence to recommended 
malaria tests and treatment and use of insecticide treated 
bed nets and intermittent preventive therapy (for preg-
nant women). CHAI primarily sought to strengthen 
the capacity of private drug shop dispensers (Accred-
ited Drug Dispensing Outlets or ‘ADDOs’) in selected 
districts to diagnose, treat and report malaria, diarrhoea 
and pneumonia.
Procedures
Data collection took place in June 2019 (Sierra Leone) 
and August 2020 (Tanzania) at mid- stage and late- stage 
periods of programme implementation, respectively. 
Approval was first sought from the director of each case 
grantee organisation. This was facilitated by the provision 
of an information sheet describing the study, inviting 
further dialogue and clearly stating that participation 
was voluntary and at the discretion of each organisation. 
Once approval was obtained from the respective direc-
tors, the lead author (CDH) liaised directly with a nomi-
nated programme representative to identify potential 
participants and to organise dates and logistics for site 
visits. Approximately 15 SSIs were purposively selected 
per case, ensuring a mix of staff directly involved in deliv-
ering the CR/GSK grant- funded project, key project 
partners or stakeholders and representatives of each 
projects’ primary target audience (eg, ADDOs, commu-
nity members).
Data collection was led by the lead author (CDH) 
in collaboration with an in- country investigator (MBJ, 
Sierra Leone and RS, Tanzania) and under supervi-
sion of the last author (JP). All SSIs took place onsite at 
multiple programme delivery locations, were conducted 
over a 1- week period for each case and variously focused 
on (depending on who the interviewee was): project 
understanding, role and experience; project team struc-
ture; perceived project outcomes and impact; pathways 
to outcome/impact; sustainability; and collaboration and 
 on O









ealth: first published as 10.1136/bm





4 Hemingway CD, et al. BMJ Global Health 2021;6:e006615. doi:10.1136/bmjgh-2021-006615
BMJ Global Health
networking. Both positive and negative consequences 
of employing a disease- specific approach on HSS were 
probed during the interview.
Interviews were conducted using predeveloped inter-
view guides in either English, Krio (Sierra Leone) or 
Swahili (Tanzania) as required. All interviews were 
conducted by two research team members, one leading 
the interview and the other taking notes. All interviews 
followed the principle of informed consent, were audio 
recorded and lasted approximately 60 min on average. 
Interviews were transcribed and when required trans-
lated into English. Audio files were deleted following 
transcription.
Data analysis
Data analysis was informed by a general inductive 
approach,20 aligning emerging themes identified in 
the data with predetermined focal areas relevant to the 
overarching study objectives. Interview transcripts were 
initially coded by the lead author (CDH), resulting 
in a data framework and draft narrative presenting 
emerging themes and subthemes under constructs of 
‘HSS evidence’ and ‘HSS facilitators’ informed by the 
literature.21 Perceived HSS contributions from the data 
were mapped to the six WHO health systems building 
blocks18 to reflect on areas where HSS was encountered 
within a defined health system and its boundaries. The 
framework and draft narrative were then shared with 
in- country investigators involved in data collection (MBJ 
and RS) and the principal investigator (JP) for critical 
review and collectively revised over three iterations. Final 
coding decisions as well as the content of the proposed 
implementation model were all agreed by consensus 
opinion. NVivo software (V.12) was used to support the 
data analysis.
Written informed consent was obtained from all study 
participants.
Patient and public involvement
No patients or members of the public were involved in 
the design, conduct or reporting of this study.
RESULTS
Sample
A total of 51 interviews were conducted across the four 
grantees; 30 in Sierra Leone (20 men and 10 women), 21 
in Tanzania (15 men and 6 women). Table 1 summarises 
the total number of participants per grantee with a break-
down by participant role. National government workers 
were questioned on both in- country grantees. The differ-
ence in sample size between the different projects was 
predominantly due to the varying size of the project 
teams.
Perceived health systems strengthening contributions
Participants perceived a number of HSS contributions 
that potentially correspond to one or more of the health 
system building blocks as defined by WHO. Beginning 
with ‘access to essential medicines’ (WHO Building Block 
4), as grantees across all four cases were reliant on the 
national supply of malaria commodities to achieve the 
targeted objectives of their project, then efforts to address 
weaknesses in the local medical supply chain, including 
both short- term and long- term solutions were frequently 
reported. Long- term solutions involved working 
with local stakeholders to alter the ordering process, 
enhancing the efficiency and reducing the risk of supply 
shortages. Short- term solutions involved the provision of 
project vehicles to collect supplies during disputes. Local 
stakeholders perceived positive effects through efforts 
to improve the supply of malaria commodities, such as 
fewer stock outs, but also recognised that these efforts 
were an ongoing process:
We’ve still been working on it trying to see with the pro-
gram [KGHP] how we can simplify the ordering process to 
ensure that when the orders are put, at least not more than 
72 hours for us to receive the commodity. We’re making 
progress but still some challenges along that line.—Physi-
cian, Sierra Leone
Relating to the supply of medical commodities which 
requires accurate and timely data to ensure supply meets 
demand, grantees reported interventions targeting 





Kings College Global Health Partnership 
(total)
12
  Grantee staff 4
  Volunteer overseas health professionals 3
  Local health workers 5
Health Poverty Action (total) 16
  Grantee staff 9
  Local health workers 2
  District government workers 2
  Partner non- government organisation staff 3
Sierra Leone National Malaria Control 
Programme (NMCP)
2
Tanzania Communication and Development 
Centre (total)
7
  Grantee staff 2
  Regional/district government workers 3
  Local health workers 2
Clinton Health Access Initiative (total) 9
  Grantee staff 1
  Regional/district government workers 4
  Local health workers 4
Tanzania NMCP 2
Tanzania presidents office, regional 
administration and local government
3
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‘health information systems’ (WHO Building Block 3). 
Two of the grantees (CHAI and HPA) reported efforts to 
strengthen the collection and use of malaria case data at 
the community and dispensary level, which by extension, 
influenced decision- making at the district level:
Another point about the positive outcome is ability for AD-
DOs now to submit reports [of malaria, pneumonia and di-
arrhoea cases treated or referred for inclusion in national 
health information system]. It’s something that the region 
were missing, that case management from the drug shops 
so through the surveillance system they can be able to as 
a region to have a visibility to get that data from the AD-
DOs.—Government Worker, Tanzania
KGHP took a different approach and set out to 
strengthen health information systems through digi-
tisation at the hospital level and consciously steered 
away from information systems specific to malaria. This 
was perceived to enable wider health system benefit as 
it supported the surveillance and monitoring of other 
health conditions.
Health workforce training (WHO Building Block 2) 
and mentorship was a frequently reported intervention, 
with all grantees reporting at least one form of health 
professional development across different levels of the 
health system; from refresher training for community 
health volunteers to training in febrile case management 
at the hospital level. While project activities maintained a 
malaria focus there was a strong will by local stakeholders 
to apply aspects of these initiatives to other health condi-
tions. For example, febrile case management training 
implemented by KGHP by extension has supported 
management of other common conditions such as enteric 
fever, tuberculosis (TB) and HIV. In addition to health 
provider training, grantees also reported training efforts 
to improve supportive supervision by district health offi-
cials, which to a degree targets ‘leadership/ governance’ 
(WHO Building Block 6). Participants also reported 
efforts beyond health workforce development to improve 
‘service delivery’ (WHO Building Block 1), for example, 
KGHP, with support from the National Malaria Control 
Programme, were able to implement malaria rapid diag-
nostic tests (mRDTs) at the hospital which was reported 
to reduce the waiting time for patients to receive their 
results and access treatment. Interventions targeting 
‘financing’ (WHO Building Block 5) were less evident 
from the data; however, there were reported initiatives 
aimed at sustaining financial incentives for community 
health volunteers beyond the lifetime of the project, for 
example, HPA were working on a village savings scheme.
A limitation of using the WHO health system building 
blocks to map the reported perceived HSS contributions 
are the divergent views on whether behaviour change 
interventions sit within the framework. While it can be 
argued that behaviour change interventions sit within 
service delivery (WHO Building Block 1), it has been 
acknowledged that the framework ‘focuses on health 
sector actions and underplays the importance of actions in 
other sectors and does not take into account actions that 
influence peoples’ behaviours, both in promoting and 
protecting health and the use of healthcare services.18’ 
Two grantees (HPA and TCDC) delivered projects specif-
ically designed to promote healthy behaviours and envi-
ronments and increase acceptability and awareness of 
malaria diagnosis and treatment in the community. Partic-
ipants from TCDC explained that while the project was 
focused on delivering malaria education and communi-
cation, the community change agents they were working 
with had been trained through previous projects to speak 
on HIV, family planning and TB, which meant that when 
they went out into the community under the FMIH grant, 
they were equipped to address a broad range of needs.
While many interventions deployed by grantees targeted 
one or more of the WHO health systems building blocks, 
most were primarily small scale and disease focused, 
achieved through close working partnerships with local 
stakeholders and ongoing access to health development 
funding.
Common approaches and experiences in pursuing HSS 
objectives
Five distinct themes emerged from across the data, each 
presented in turn below.
Short-term funding for long-term initiatives
Findings indicate that grantees were employing the 
relatively short- term FMIH grant (2–3 years) to support 
longer- term initiatives (eg, 10+ years). Grantees were 
cognisant that their interventions required ongoing 
technical assistance and external funding beyond the life 
of the project to be successfully maintained, embedded 
and scaled- up. Soft funding was treated by grantees as a 
means to an end, where in most cases the end was not 
achieved under the FMIH programme grant, but progress 
was made. In Tanzania, the idea to target ADDOs for 
the improvement of malaria case management at the 
primary level was first conceived and explored in 2012. 
A feasibility study conducted in 2014–2015 resulted in 
adoption of the ADDO programme by the Tanzania 
National Malaria Control Program (TNMCP). The 2017 
FMIH programme grant was used to support the TNMCP 
in rolling out the ADDO programme nationwide. In 
2020, at the time of interview, government stakeholders 
reported a strong desire to sustain and expand the 
geographical and disease focus of the ADDO programme 
with the prerequisite of external funding:
At that primary stage we still have other diseases which can 
be also included [in the ADDO program], because now we 
are concentrating with the malaria and the rare pneumo-
nia. But if you go further you can find that there is other 
diseases…I think it is very important to add those diseas-
es especially some of those which are neglected tropical 
diseases… currently the government is actually supporting 
the program but partners are also supporting. We are sure 
that we cannot, actually it’s the government, do it our-
selves.—Government Worker, Tanzania
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Interviewees provided examples of ongoing nation-
wide roll out of the ADDO programme through support 
from other external donors and development partners. 
In addition, government pressure was being applied 
to the pharmacy council to expand the 6- week manda-
tory inception training for ADDOs to incorporate the 
management of fever focusing on malaria, diarrhoea 
and pneumonia as is currently provided by CHAI within 
the context of their grant. For TCDC, the FMIH funding 
enabled the continuation and geographical expansion 
of technical and financial support for social and behav-
iour change communication provided to the government 
since 2008.
In Sierra Leone, funding was used directly or indi-
rectly for the continuation of a range of long- term HSS 
initiatives which began years before receipt of the FMIH 
programme grant, these included: training in case 
management at the tertiary level; increased access and 
improved management of ambulances at the district level; 
continuation of a health and well- being school education 
programme; improved management and use of hospital 
records; patient empowerment through employment 
of a patient advocate; and continuation of village devel-
opment committees, empowering local communities to 
effectively advocate for better health services. HPA viewed 
the FMIH programme grant as an opportunity to sustain 
and expand on their maternal and child health work:
…the Impact project [FMIH programme grant] from the 
design, it is an integrated project…We integrate malaria 
into an existing project which is more focused on maternal 
and child health. Most of the interventions in the Impact 
project were interventions that were ongoing in our mater-
nal and child health project…It was like a complementary 
project.—HPA employee
Embedded in the local health system
Grantees in Sierra Leone and Tanzania represented 
organisations who were already embedded in the local 
health system, at the primary level (CHAI, TCDC and 
HPA) and tertiary level (KGHP). To a varying degree, 
grantees were known to and trusted by government 
health units and viewed as integral for the implementa-
tion of their strategic plans. From this position grantees 
were cognisant of the political and health system needs, 
capabilities and priorities and at the same time were 
influential in shaping them. Clear examples where the 
grantees collaborated with local health and government 
workers prior to applying for funding were evident in the 
data:
I was nominated by the Malaria Control Program to do 
some training in management of malaria in the tropics…
When I came back, the Malaria Control Program manager 
informally acknowledge me to be a focal person for malar-
ia at Connaught Hospital…Even before the SHIFT project 
[FMIH programme grant] start, I started looking into the 
way malaria patients are being treated and what are some 
of the challenges and all. That’s how I came to know about 
KGHP and this comic relief. We put together the research 
projects and submitted, and we got this approval.—Physi-
cian, Sierra Leone
Local stakeholders valued these close relationships, 
viewing grantees as ‘part and parcel’ of their organisa-
tion, enabling them to establish a sense of ownership of 
grantee activities from the outset.
Understanding of government priorities and the land-
scape of development partner activities was obtained 
through informal social interactions and a range of formal 
partner and government forums. Grantees reported key 
benefits from engaging in these forums; from enabling 
them to collaborate with other partners working in their 
area enhancing the efficiency and scope of their work, 
to facilitating the incorporation of project activities into 
the local government work plans and budgets. When 
engagement in partner and government forums occurs 
after the receipt of grant money the flexibility of devel-
opment partners to address government priorities and 
avoid duplication is constrained as they are contracted 
to meet the objectives set out in the funding proposal. 
While there were still reported imbalances in develop-
ment partner support, both within the malaria response 
and for other health conditions, frequent interaction 
and the close working relationship between government 
bodies and grantees prior to the commencement of the 
FMIH programme grant mitigated against the risk of 
duplication and distortion.
They [TCDC] meet with the regional health management 
team (RHMT), they discuss the planning on how those ac-
tivities [grantee activities] will be conducted. Maybe on a 
quarterly basis or monthly basis, depending on the need…
So every partner will come with these plans… So among 
those activities which we have planned, those activities are 
discussed. Once they are discussed and we have agreed on 
each term that the activities will be conducted, and then 
some members of the RHMT, they have to supervise us 
during the implementation of such activities.—Govern-
ment Worker, Tanzania
Donor flexibility enabling grantee responsiveness
The interviews demonstrated that how the donor oper-
ates was key to enabling grantees to pursue feasible 
and responsive HSS. Grantees commended the FMIH 
programme for their flexibility and support when project 
plans had to be adapted in response to evolving condi-
tions and local priorities. For KGHP, this involved scaling 
back implementation of a hospital information manage-
ment system to focus on the diagnostic laboratory; 
beginning with a closed system that could be expanded 
given greater time and resources, while ensuring impact 
was achieved under the grant by executing changes at 
a feasible scale for the hospital. For CHAI, unforeseen 
government pressure prevented the roll out of mRDTs 
to the ADDOs in 2017. Rather than lose time waiting for 
government approval CHAI was able to redirect efforts to 
improve malaria diagnostic services at private laborato-
ries through roll out and training in mRDTs.
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Stated or tacit understanding by the grantees of donor 
flexibility enabled them to be responsive, to support 
other programmes and to do more where reasonable 
and with justification. Not only did this allow grantees to 
make changes to address difficulties but it also allowed 
them to work opportunistically to maximise impact. 
This understanding influenced grantee decisions during 
both project design and implementation. From HPA’s 
approach, integrating the malaria project with their 
existing maternal and child health programme to facil-
itate the continuation and expansion of this work rather 
than proceed with a ‘stand alone malaria intervention 
project’. To KGHPs approach to strengthening data 
systems, as illustrated by this quote:
They were quite respectful of the need to strengthen data 
systems, not just let’s have an electronic platform for ma-
laria. Similarly, we said we want to do training on manage-
ment of fever rather than on the management of malaria…
yes, the funding is malaria focused but comes together in 
that context.—KGHP employee
Without this understanding grantees may have been 
reluctant to expand project activities beyond a malaria 
focus or respond to opportunities during the project.
Modest expectations
In contexts with seriously underfunded health systems, 
even if improvements can be achieved with targeted 
external support, they cannot easily be sustained after 
the period for which donor agencies are usually ready to 
commit funding. Grantees believed the donor was guilty 
of expecting too much from 2 to 3 year funding in terms 
of scale and sustainability of HSS activities, as illustrated 
by this quote:
One is that health systems reform is complicated and takes 
quite a long time to do it right. With hindsight, we were 
encouraged by Comic Relief that we would be unlikely to 
get the grant unless we were grandiose about the ideas 
that we were pitching. The potential of a national scale up 
and multi- disciplinarily and so on. I think it was right to 
do something that was quite broad. It was right to think of 
what could be the lessons that are transferable. One of the 
outputs from the project will be to have some toolkits that 
hospitals can use. I think we would have written a slightly 
less ambitious but more achieving, a more impactful pro-
posal perhaps if we’d less felt less pressurized into doing so 
much.—KGHP employee
The quote above speaks to the notion that HSS may be 
best achieved through gradual, long- term application of 
a consistent approach. The need to demonstrate innova-
tion and ambition in a project proposal can derail these 
‘slow and steady’ approaches if they are not appealing 
enough to continuously attract funding.
For grantees focused on behaviour change interven-
tions, there was the view that donor expectations for 
sustained impact on disease outcomes was unattainable 
given the nature of human behaviour and resource 
constraints preventing adoption of these activities by 
local government; resulting in resources being directed 
to interventions which had a more tangible and direct 
impact on health outcomes, as illustrated by this quote:
When it comes to behaviour change, usually it is a process, 
and most of the donors, most of the people, especially the 
government itself as well and other stakeholders, they have 
a lot of expectations. When it comes to when you are get-
ting a fund, they want to get results…Sometimes, it’s not 
easy to be able to measure the change, it is very challeng-
ing… And on the other side, the government has been 
putting more effort in when it comes to the tangible stuff, 
putting more money and support into equipment, health 
facilities, building more facilities, stuff like those. Getting 
them to focus on the soft things which they cannot touch 
like behaviour and education is somewhat also tricky and 
challenging.—TCDC employee
The participant noted that this issue was not unique to 
the FMIH programme.
Micro-innovation
While expectations of ambitious and highly innovative 
project proposals may not always support HSS, micro- 
innovations appear essential. The focus of the grantees 
was not to introduce new service providers or prod-
ucts but to improve the quality and uptake of existing 
services though micro- innovation. This approach could 
be seen clearly in activities to sustain community health 
worker (CHW) motivation through financial incentives. 
Grantees in Sierra Leone and Tanzania were cognisant 
of limitations in CHWs relying on external funding to 
finance their community health work in the absence of 
adequate government support. To address this limitation, 
TCDC was piloting financial management training with 
CHWs and allocating small loans through community- 
based organisations to enable CHWs to establish income 
generating activities. HPA reported intentions to support 
a village saving scheme in which the community would be 
responsible for paying the CHWs:
there is a village and saving loan scheme. It is very, very, 
very important…most of the projects that has been sus-
tained today in Sierra Leone, those are the approaches 
they took…now, the narrative is changing. Even the com-
munities, they want to do it themselves, sure. By the end of 
the project, if we have that scheme, I’m pretty sure that the 
impact will just resemble like the impact is still going on 
within a community.—HPA employee
Grantees also provided example of micro- innovation 
that were both simple to execute and easily sustainable 
which seemingly contributed towards health system 
strengthening. For example, to improve patient under-
standing of which services and commodities are free 
and which must be paid for, KGHP supported hospital 
management to post two large price lists at strategic 
points, in the entry point of accident and emergency and 
where payments are made. Transparent pricing improves 
patient access to health services and helps prevent fraud-
ulent charges sometimes imposed by healthcare workers, 
thereby improving service quality.
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DISCUSSION
Participants reported wide ranging contributions towards 
HSS, many of which mapped onto the WHO’s health 
systems building blocks such as the health workforce, 
health service delivery, health information systems and 
access to medicines. Some contributions were unequiv-
ocally health systems strengthening, such as improved 
National Health Information System data capture, 
whereas other reported contributions may have been 
more contentious in terms of whether they amounted to 
actual health system strengthening as opposed to disease 
specific health systems support.22 For example, most 
grantees supported supply chain strengthening in some 
capacity, arguably motivated by the need to ensure a reli-
able supply of malaria commodities to satisfy the demands 
of their respective malaria- control projects. Most of the 
reported HSS contributions were seemingly modest in 
scale and some, such as the provision of project vehicles 
to collect supplies, would be unsustainable once project 
support is removed further questioning their merit as a 
genuine HSS outcome. In this respect, the study findings 
mirror ongoing debates in the HSS literature pertaining 
to what is, and what is not, a HSS activity. The purported 
HSS activities of primarily disease- based programmes 
have been challenged on the grounds that they do not 
align with more widely recognised HSS frameworks as 
has the validity of so called ‘spill over’ effects in which 
activities undertaken in support of a disease- specific 
programme are said to have broader benefit across the 
health system.10 23 The reported HSS outcomes reported 
herein remain open to the same challenges.
Even if some perceived HSS contributions were over-
stated, the study findings suggest that grantee organisa-
tions structured and operated their respective projects in 
a manner generally supportive of HSS objectives. This is 
revealed through the commonalities identified across the 
four grantee organisations in terms of their respective 
approach to pursuing their HSS objectives, and experi-
enced tensions in pursuit of these objectives. Commonal-
ities included: (1) using short- term funding for long- term 
initiatives; (2) benefits of being embedded in the local 
health system; (3) donor flexibility to enable grantee 
responsiveness; (4) the need for modest expectations; 
and (5) the importance of micro- innovation. Of these 
five commonalities, a number were reflective of widely 
accepted principles of HSS such as meaningful collabora-
tion with government partners from planning through to 
implementation, coordinating activities with other sector 
partners and ensuring sustainable funding and interven-
tion strategies.4 24 Donor flexibility has previously been 
identified as an important factor in aid effectiveness,25 
although arguably runs counter to prevailing notions 
of strict accountability in development funding expen-
diture and the prioritisation of targeted technical HSS 
intervention with clear and measurable outcomes.25 26 
Our study findings suggest donor flexibility and grantee 
responsiveness in programme implementation, allowing 
HSS opportunities to be identified and accommodated, 
may be especially important HSS ‘enabling’ factors. This 
may be considered a form of ‘bottom up’ approach, in 
which organisations are empowered to ‘self- organise’ and 
develop context appropriate approaches based on their 
knowledge of local health systems.27 Embedded partners 
are perhaps best placed to operate in this way, although 
such licence to ‘self- organise’ should still be grounded 
within an evidence- based approach to decision- making.24
The modest nature and uncertain sustainability of 
many perceived HSS outcomes were perhaps indicative 
of the limited available time and resources within the 
FMIH project life spans. Actual health systems strength-
ening goes beyond investing in inputs; it requires 
reforming how the health system operates to ensure 
resilience and quality, and this cannot be achieved in a 
2–3 year period.28 Grantees sought to overcome these 
limitations to the benefit of the country by linking a 
series of short- term grants together. However, linking 
short- term grants requires a ‘continuation’ policy that 
is not always attractive to funders looking for innova-
tion and attributable impact. Thus, funder support for 
the continuation, adaptation and/or scale up of proven, 
locally- embedded programmes may be central to HSS 
as is the realisation that outcomes during the course of 
any one grant may be modest and largely unattributable 
to a single source. Meanwhile, the onus remains on the 
programme implementers to regularly micro- innovate 
and, where necessary to ensure programme continua-
tion, share resources and expertise with other actors in 
the local health system as has been argued, for example, 
in the context of development partner support for 
community health worker programmes.29 These find-
ings further reveal the symbiotic relationship between 
donor and grantee in the pursuit of HSS outcomes: the 
donor provides the conducive environment in which a 
responsive grantee can support broader HSS objectives 
in their respective project settings. The less flexible the 
donor and/or the less responsive the grantee, the harder 
it may fully be to realise HSS objectives within the context 
of a primarily disease- specific grant. Findings from this 
study also suggest that the FMIH programme may have 
benefitted from providing grantees with a definition of 
HSS informed by the literature. Ambiguity in what consti-
tutes HSS could dilute the term within the global health 
field, with grantees and donors promoting disease- 
specific health system support as HSS. For example, ad 
hoc training of health workers was commonly practiced 
among grantees and was perceived as a HSS intervention, 
yet many would challenge this claim on the basis that 
national reform to the professional development stan-
dards would be required to constitute HSS.
Drawing on these study findings, figure 1 presents a 
hypothetical implementation model that may enhance 
the potential of disease- specific programme grants to 
facilitate HSS in low- income and middle- income country 
contexts. The model focuses on both donor and grantee 
actions, recognising the symbiotic relationship between 
the two. The model content is grounded solely within our 
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study data and, as such, is not presented as a synthesis 
of (or alternative to) existing HSS frameworks or proven 
principles even though commonalities exist (as discussed 
above). In this respect the model may be considered the 
conceptual outcome of a qualitative research method-
ology akin to grounded theory approaches.30 The model 
presents actions hypothesised to be supportive of HSS 
from project design through to post implementation and 
sustainability. Actions on the left align with those on the 
right. From the grantee’s perspective, actions supportive 
of HSS begin at project design, which involves working 
with local stakeholders and positioning the grant within a 
long- term strategic plan to formulate appropriate objec-
tives and outcome measures. It requires considering 
what the grant can feasibly contribute to existing or new 
strategic plans with an understanding that short- term 
disease- specific grants are a means to make progress with 
additional funding required in the long- term. During 
Figure 1 A hypothetical implementation model that may enhance the potential of disease- specific programme grants to 
facilitate health system strengthening (HSS) in low- income and middle- income country contexts.
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implementation, the stated actions reiterate the need 
for gradual and responsive approaches and the impor-
tance of maintaining a close working relationship with 
local stakeholders during planning and implementation, 
which may enhance the sustainability of grant activities. 
The remaining actions highlight the potential benefits 
of cross- programme collaboration to support scale up 
and wider application of grant activities which requires 
openness and transparency. From the donor’s perspec-
tive, the stated actions reiterate the importance of 
empowering embedded and trusted organisations, while 
holding reasonable expectations for HSS through short- 
term grants and being supportive of gradual approaches 
and objectives which expand beyond the disease focus. 
The actions within ‘donor support’ highlight the need 
to foster and resource an environment in which grantees 
can effectively collaborate and act responsively.
The reported study was not without limitation. Only 4 
out of the 23 FMIH grantees were included in the study 
as were only two out of the five participating countries/
regions. HSS experiences may have been different for 
other grantees in the same or other contexts and, as 
such, the reported findings should not be considered 
representative of the entire FMIH initiative. Data collec-
tion took place in June 2019 (Sierra Leone) and August 
2020 (Tanzania) at mid- stage and late- stage periods of 
programme implementation, respectively; as such the 
level of impact and experience in HSS may have differed 
between the two focal countries. Having said that, the five 
identified commonalities were consistent across all four 
grantees included in the study suggesting some degree 
of generalisability. Certain terms used by interview partic-
ipants did not have a direct English translation which, at 
times, led to ambiguity in the data during the translation 
process. To mitigate against the risk of misinterpretation, 
transcription and translation of interviews not conducted 
in English was carried out by MBJ and RS (fluent in Krio 
and Swahili, respectively). While perceived HSS contri-
butions were reported and in some cases observed, the 
study did not seek to robustly measure the extent of HSS 
attained via grantee programmes; thus, it is not possible 
to infer the degree to which the reported ‘common 
factors’ did (or did not) contribute to HSS or the rela-
tive influence of each factor on HSS. It is for this reason 
that we present the subsequent implementation model as 
hypothetical. Further research will be needed to verify if 
the proposed model remains valid within the context of a 
disease- specific programme with proven HSS impact. The 
in- country investigator from Tanzania (RS) was also an 
employee of one of the case programmes (CHAI) raising 
the possibility of researcher- bias and/or participant- bias. 
To minimise the risk of the former, data analysis and 
reporting were conducted collaboratively and iteratively 
by four authors (CDH, MBJ, RS and JP) until consensus 
opinion was achieved. To reduce the risk of the latter, RS 
rarely sat in on participant interviews unless interpreta-
tion was needed in which case the provisions of partici-
pant confidentiality were clearly explained.
CONCLUSION
The experience of the four grantee organisations 
included in our qualitative study suggests HSS may be 
pursued through disease- specific programme grants; 
however, the respective practice of both the funder and 
programme implementers appears to be a key influence 
on whether HSS will be realised as well as the overall 
extent of HSS possible to achieve. Practices that enable 
continuation of proven programmes, delivered by part-
ners embedded (or committed to embedding) within the 
local health system, that are responsive to local needs and 
HSS opportunities and that encourage micro- innovation 
may be especially powerful enablers of HSS within the 
context of a disease- specific programme grant; even 
more so if expectations of what level of HSS is achievable 
within often short- term programme time frames are real-
istically set. Our hypothesised HSS- supportive implemen-
tation model will need to be further tested in a disease- 
specific programme with proven HSS impact.
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